Eculizumab - PDFSEARCH.IO - Document Search Engine

Eculizumab
Results: 59

#	Item
41	Microsoft Word - soliris_qn_aa_155506-eng.docx Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2014-10-08 10:01:47 Pharmaceutical sciences Alexion Pharmaceuticals Clinical trial Pharmacovigilance Regulatory compliance Adverse effect Alternative medicine Eculizumab Pharmacology Medicine Health
42	Microsoft Word - soliris_dhcpl_lapds_155506-eng.doc Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2014-10-08 10:01:47 Immunosuppressants Alexion Pharmaceuticals Acquired hemolytic anemia Patient safety Hemolytic-uremic syndrome Meningococcal disease Adverse effect Meningococcal vaccine Hus Medicine Health Eculizumab
43	Eculizumab (Soliris®) Injectable Medication Precertification Request (All fields must be completed and legible for Precertification Review) Start of treatment: Start date / Add to Reading List Source URL: www.aetna.com Language: English - Date: 2013-02-07 04:18:56 Immunosuppressants Hematopathology Paroxysmal nocturnal hemoglobinuria Aplastic anemia Neisseria meningitidis Medicine Health Eculizumab
44	[removed]SOLIRIS® (eculizumab) Humanized First in Class Anti - C5 Antibody Human Framework Regions • No mutations Add to Reading List Source URL: www.aamds.org Language: English - Date: 2014-07-24 09:35:18 Orphan drugs Immunosuppressants Proteobacteria Eculizumab Meningococcal disease Alexion Pharmaceuticals Neisseria meningitidis Neisseria Paroxysmal nocturnal hemoglobinuria Bacteria Medicine Health
45	Morbidity and Mortality Weekly Report Recommendations and Reports / Vol[removed]No. 2 March 22, 2013 Prevention and Control of Meningococcal Disease Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-03-21 11:49:21 Health Meningococcal disease Meningococcal vaccine Meningitis NmVac4-A/C/Y/W-135 Advisory Committee on Immunization Practices Pneumococcal conjugate vaccine FluMist Eculizumab Vaccines Medicine Vaccination
46	Current as of[removed]This document may not be part of the latest approved REMS. ~ hi . Add to Reading List Source URL: www.fda.gov Language: English Eculizumab Immunosuppressants
47	CANADA COMMUNICABLE DISEASE REPORT CCDR JANUARY 2013 • VOLUME 39 • ACS-1 ISSN[removed] Add to Reading List Source URL: www.atlantique.phac.gc.ca Language: English - Date: 2013-09-17 16:59:15 Pharmacology Meningococcal vaccine Meningococcal disease Eculizumab Vaccination schedule Neisseria Meningitis Pneumococcal vaccine DPT vaccine Vaccines Medicine Health
48	CANADA COMMUNICABLE DISEASE REPORT CCDR JANUARY 2013 • VOLUME 39 • ACS-1 ISSN[removed] Add to Reading List Source URL: www.phac-aspc.gc.ca Language: English - Date: 2013-09-17 16:59:15 Pharmacology Meningococcal vaccine Meningococcal disease Eculizumab Vaccination schedule Neisseria Meningitis Pneumococcal vaccine DPT vaccine Vaccines Medicine Health
49	Office of Vermont Health Access Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-01-24 11:00:21 Pharmacy Drug safety Clinical pharmacology Food and Drug Administration United States Public Health Service Eculizumab Pharmacovigilance Pharmaceutical sciences Pharmacology Medicine
50	SOLIRIS® (ECULIZUMAB) RECOMBINANT HUMANIZED MONOCLONAL ANTIBODY Alexion Pharmaceuticals, Inc. Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Vaccines Eculizumab Immunosuppressants Meningococcal disease Alexion Pharmaceuticals Neisseria meningitidis Meningococcal vaccine Meningitis Medicine Health Bacteria